Six-membered heterocyclic compound and the use thereof

Details for Australian Patent Application No. 2006209543 (hide)

Owner Asahi Kasei Pharma Corporation

Inventors Shoda, Motoshi; Ishizuya, Toshinori

Agent Watermark

Pub. Number AU-B-2006209543

PCT Pub. Number WO2006/080323

Priority 2005-019185 27.01.05 JP; 2005-330079 15.11.05 JP

Filing date 25 January 2006

Wipo publication date 3 August 2006

Acceptance publication date 30 April 2009

International Classifications

C07D 237/04 (2006.01) Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

A61K 31/50 (2006.01) - Pyridazines

A61P 1/02 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

20 September 2007 PCT application entered the National Phase

  PCT publication WO2006/080323 Priority application(s): WO2006/080323

30 April 2009 Application Accepted

  Published as AU-B-2006209543

27 August 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006209547-Anticancer drug containing alpha,alpha,alpha-trifluorothymidine and thymidine phosphorylase inhibitor

2006209523-Spiroketal derivative and use thereof as diabetic medicine